Bath & Body Works, Inc. (NYSE:BBWI) Shares Bought by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd increased its position in Bath & Body Works, Inc. (NYSE:BBWI) by 93.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,375 shares of the company’s stock after buying an additional 14,225 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Bath & Body Works were worth $1,139,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. South Dakota Investment Council raised its position in Bath & Body Works by 2.2% in the fourth quarter. South Dakota Investment Council now owns 429,504 shares of the company’s stock worth $16,652,000 after acquiring an additional 9,063 shares in the last quarter. Howard Capital Management Inc. acquired a new position in shares of Bath & Body Works in the 4th quarter worth approximately $363,000. Wealthspire Advisors LLC bought a new stake in shares of Bath & Body Works in the 4th quarter worth approximately $213,000. Tandem Investment Advisors Inc. acquired a new stake in Bath & Body Works during the fourth quarter valued at approximately $215,000. Finally, Forte Capital LLC ADV acquired a new stake in Bath & Body Works during the fourth quarter valued at approximately $211,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

Shares of BBWI opened at $41.04 on Thursday. The firm has a market cap of $8.89 billion, a PE ratio of 10.01, a PEG ratio of 0.92 and a beta of 1.83. The firm’s 50 day moving average price is $37.82 and its 200 day moving average price is $34.07. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. The company had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.48 earnings per share. On average, sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be issued a $0.20 dividend. The ex-dividend date is Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 1.95%. Bath & Body Works’s dividend payout ratio (DPR) is currently 19.51%.

Wall Street Analysts Forecast Growth

BBWI has been the topic of several research reports. JPMorgan Chase & Co. raised Bath & Body Works from a “neutral” rating to an “overweight” rating and upped their price target for the company from $41.00 to $47.00 in a report on Tuesday, February 18th. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Morgan Stanley reduced their target price on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a report on Thursday, November 21st. Piper Sandler lifted their price target on Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. Finally, Barclays raised shares of Bath & Body Works from an “underweight” rating to an “equal weight” rating and boosted their target price for the company from $34.00 to $43.00 in a research note on Monday. Six research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, Bath & Body Works has a consensus rating of “Moderate Buy” and an average target price of $44.44.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.